Oxnard’s Cure makes $20M buy of CBD firm

You are here: Home > Agribusiness > Current Article

By Staff Report / Tuesday, July 28th, 2020 / Comments Off on Oxnard’s Cure makes $20M buy of CBD firm

Cure Pharmaceutical, an Oxnard-based public company working on drug delivery systems and cannabis therapies, said July 28 that it has agreed to acquire Sera Labs, a privately owned CBD company, in a 95-percent stock deal that includes $19 million in stock at $2.75 per share. Cure, which shares are traded over the counter, closed unchanged at…

This article is only available to Business Times subscribers

Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
Check the STATUS of your Subscription Account.